日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53

针对 Mortalin 和突变型 p53 的新型卵巢癌维持疗法

Satish K Ramraj, Sugantha P Elayapillai, Richard C Pelikan, Yan D Zhao, Zitha R Isingizwe, Amy L Kennedy, Stanley A Lightfoot, Doris M Benbrook

12-HETrE inhibits platelet reactivity and thrombosis in part through the prostacyclin receptor

12-HETrE 部分通过前列环素受体抑制血小板反应性和血栓形成。

Tourdot, Benjamin E; Adili, Reheman; Isingizwe, Zitha R; Ebrahem, Meral; Freedman, J Cody; Holman, Theodore R; Holinstat, Michael